{"id":128397,"date":"2021-10-01T13:24:37","date_gmt":"2021-10-01T20:24:37","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2021\/10\/new-foundation-will-distribute-1bn-for-aging-research"},"modified":"2021-10-01T13:24:37","modified_gmt":"2021-10-01T20:24:37","slug":"new-foundation-will-distribute-1bn-for-aging-research","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2021\/10\/new-foundation-will-distribute-1bn-for-aging-research","title":{"rendered":"New foundation will distribute $1bn for aging research"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/new-foundation-will-distribute-1bn-for-aging-research2.jpg\"><\/a><\/p>\n<p>\u201cThe Foundation has created a unique and transparent mechanism for boosting early longevity research worldwide and ensuring mass public participation in decision making,\u201d said Alex Zhavoronkov, Visionary Board member and an expert in AI-powered drug discovery. \u201cThis approach finally allows us to speak about getting closer to the idea of mass adoption of longevity ideas and treatments.\u201d<\/p>\n<p>\u201cAge is the greatest risk factor for nearly every major cause of death and disability in developed nations. Therapeutically targeting biological aging is key to fulfilling the promise of 21st century medicine, and the Foundation is poised to play a central role in making this a reality,\u201d said Matt Kaeberlein, CEO of the American Aging Association and Professor at the University of Washington, where he leads several major initiatives.<\/p>\n<p>\u201cIn five years, healthy longevity will not only exist as a lab-proven concept, but will become part of everyone\u2019s life,\u201d said Andrea Maier, Visionary Board member and co-director of the Centre for Healthy Longevity at the National University of Singapore.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u201cThe Foundation has created a unique and transparent mechanism for boosting early longevity research worldwide and ensuring mass public participation in decision making,\u201d said Alex Zhavoronkov, Visionary Board member and an expert in AI-powered drug discovery. \u201cThis approach finally allows us to speak about getting closer to the idea of mass adoption of longevity ideas [\u2026]<\/p>\n","protected":false},"author":566,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,269],"tags":[],"class_list":["post-128397","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-life-extension"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/128397","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/566"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=128397"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/128397\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=128397"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=128397"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=128397"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}